GlassScriptPhysician profile
Sampson Ws Ho
NPI 1437192374
$3,584.59
in general payments reported to CMS, 2019-2025
22 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $363 · 2021: $781 · 2022: $619 · 2023: $471 · 2024: $397 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Piramal Critical Care | $704.93 | 2019-2025 | |
| Abbvie INC. | $605.62 | 2022-2025 | |
| Allergan, INC. | $591.04 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $291.45 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $285.83 | 2019-2022 | |
| Ibsa Pharma INC. | $238.47 | 2021-2023 | Tirosint, Licart |
| E.R. Squibb & Sons, L.L.C. | $121.70 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $106.94 | 2024-2025 | |
| Smith+Nephew, INC. | $97.61 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $81.73 | 2023-2024 | Xeomin |
| Assertio Therapeutics, INC. | $77.79 | 2019 | |
| Pfizer INC. | $71.20 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $66.74 | 2019-2021 | |
| Amgen INC. | $48.80 | 2019-2024 | Prolia, Evenity |
| Biogen, INC. | $45.86 | 2024-2025 | Skyclarys |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $31.13 | 2023 | Nuedexta |
| Almatica Pharma LLC | $25.70 | 2021 | |
| Dynasplint Systems INC. | $24.20 | 2025 | Dynasplint |
| Dentsply Ih Ab | $20.53 | 2024 | Navina Rectal Catheter Set Regular |
| Novo Nordisk INC | $18.12 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.72 | 2019 | |
| Medtronic USA, INC. | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sampson Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.